VBI Vaccines Inc. (VBIVQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
VBI Vaccines Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -82.99 | -92.84 | -113.3 | -69.75 | -46.23 | -54.81 | Upgrade
|
Depreciation & Amortization | 1.98 | 1.99 | 2.06 | 1.84 | 1.65 | 1.2 | Upgrade
|
Other Amortization | 1.89 | 1.88 | 1.71 | 3 | 1.57 | 1 | Upgrade
|
Asset Writedown & Restructuring Costs | 24.6 | 24.6 | - | - | - | 6.29 | Upgrade
|
Stock-Based Compensation | 5.23 | 6.66 | 9.7 | 9.63 | 5.29 | 3.94 | Upgrade
|
Other Operating Activities | 7.47 | 9.69 | 30.16 | -0.32 | 0.81 | 0.3 | Upgrade
|
Change in Accounts Receivable | 0.05 | 0.1 | -0.09 | 0.07 | 0.13 | -0.14 | Upgrade
|
Change in Inventory | -5.34 | -3.72 | -5.69 | -0.51 | -1.95 | -0.39 | Upgrade
|
Change in Accounts Payable | -0.94 | -6.65 | 8.89 | 0.36 | 2.06 | -5.18 | Upgrade
|
Change in Unearned Revenue | 6.11 | 6.36 | 0.02 | -0.33 | -0.77 | -1.69 | Upgrade
|
Change in Other Net Operating Assets | -9.05 | -8.95 | -7.15 | 16.12 | -9.61 | 0.76 | Upgrade
|
Operating Cash Flow | -51 | -60.88 | -73.7 | -39.91 | -47.05 | -48.71 | Upgrade
|
Capital Expenditures | -0.48 | -0.87 | -4.34 | -2 | -1 | -3.67 | Upgrade
|
Investment in Securities | - | - | - | 25.15 | -25 | - | Upgrade
|
Investing Cash Flow | -0.48 | -0.87 | -4.34 | 23.16 | -26 | -3.67 | Upgrade
|
Long-Term Debt Issued | - | - | 20 | 12 | 20 | - | Upgrade
|
Total Debt Issued | - | - | 20 | 12 | 20 | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -15.3 | - | Upgrade
|
Total Debt Repaid | - | - | - | - | -15.3 | - | Upgrade
|
Net Debt Issued (Repaid) | - | - | 20 | 12 | 4.7 | - | Upgrade
|
Issuance of Common Stock | 25.14 | 24.27 | 0.01 | 33.38 | 124.33 | 40.25 | Upgrade
|
Other Financing Activities | -1.6 | -1.58 | -0.56 | -1.09 | -6.63 | -2.84 | Upgrade
|
Financing Cash Flow | 23.54 | 22.7 | 19.45 | 44.29 | 122.39 | 37.42 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.14 | 0.11 | -0.48 | 0.33 | 0.27 | -0.09 | Upgrade
|
Net Cash Flow | -27.8 | -38.94 | -59.07 | 27.87 | 49.61 | -15.06 | Upgrade
|
Free Cash Flow | -51.48 | -61.75 | -78.04 | -41.9 | -48.05 | -52.39 | Upgrade
|
Free Cash Flow Margin | -547.03% | -711.24% | -7212.48% | -6640.73% | -4528.75% | -2358.62% | Upgrade
|
Free Cash Flow Per Share | -2.63 | -3.97 | -9.07 | -4.93 | -6.60 | -13.16 | Upgrade
|
Cash Interest Paid | 6.26 | 6.13 | 3.23 | 2.04 | 1.61 | 2.03 | Upgrade
|
Levered Free Cash Flow | -29.1 | -39.41 | -47.53 | -13.55 | -29.88 | -36.54 | Upgrade
|
Unlevered Free Cash Flow | -25.89 | -36.25 | -45.97 | -13.36 | -29.38 | -35.65 | Upgrade
|
Change in Net Working Capital | 2.89 | 9.46 | 2.25 | -19.69 | 8.06 | 8.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.